Endpoints News 生物医药· Reynald Castaneda·· 24 天前AI 评分31
诺华考虑绕过欧洲政府支付方因MFN
Novartis considers bypassing European government payers due to MFN
AI 导读
诺华CEO Vas Narasimhan表示,欧洲私人市场或自费市场推出新药并非不可行,但未提及具体策略或数据支持。该表态出现在Endpoints News报道中,未涉及药物名称、试验阶段或监管动作细节。企业未明确说明MFN政策对药品定价或医保谈判的影响。
正文
Novartis CEO Vas Narasimhan said Tuesday that launching new drugs in the private market or in a self-pay market in Europe is not off the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源:Endpoints News 生物医药 · endpoints.news